Compounds > carbapenems
Page last updated: 2024-09-04

carbapenems and zithromax

carbapenems has been researched along with zithromax in 8 studies

Compound Research Comparison

Studies
(carbapenems)		Trials
(carbapenems)		Recent Studies (post-2010)
(carbapenems)		Studies
(zithromax)		Trials
(zithromax)		Recent Studies (post-2010) (zithromax)
7,3551475,2776,9641,2633,790

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)zithromax (IC50)
30S ribosomal protein S6Escherichia coli K-120.3
30S ribosomal protein S7Escherichia coli K-120.3
50S ribosomal protein L15Escherichia coli K-120.3
50S ribosomal protein L10Escherichia coli K-120.3
50S ribosomal protein L11Escherichia coli K-120.3
50S ribosomal protein L7/L12Escherichia coli K-120.3
50S ribosomal protein L19Escherichia coli K-120.3
50S ribosomal protein L1Escherichia coli K-120.3
50S ribosomal protein L20Escherichia coli K-120.3
50S ribosomal protein L27Escherichia coli K-120.3
50S ribosomal protein L28Escherichia coli K-120.3
50S ribosomal protein L29Escherichia coli K-120.3
50S ribosomal protein L31Escherichia coli K-120.3
50S ribosomal protein L31 type BEscherichia coli K-120.3
50S ribosomal protein L32Escherichia coli K-120.3
50S ribosomal protein L33Escherichia coli K-120.3
50S ribosomal protein L34Escherichia coli K-120.3
50S ribosomal protein L35Escherichia coli K-120.3
50S ribosomal protein L36Escherichia coli K-120.3
30S ribosomal protein S10Escherichia coli K-120.3
30S ribosomal protein S11Escherichia coli K-120.3
30S ribosomal protein S12Escherichia coli K-120.3
30S ribosomal protein S13Escherichia coli K-120.3
30S ribosomal protein S16Escherichia coli K-120.3
30S ribosomal protein S18Escherichia coli K-120.3
30S ribosomal protein S19Escherichia coli K-120.3
30S ribosomal protein S20Escherichia coli K-120.3
30S ribosomal protein S2Escherichia coli K-120.3
30S ribosomal protein S3Escherichia coli K-120.3
30S ribosomal protein S4Escherichia coli K-120.3
30S ribosomal protein S5Escherichia coli K-120.3
30S ribosomal protein S8Escherichia coli K-120.3
30S ribosomal protein S9Escherichia coli K-120.3
50S ribosomal protein L13Escherichia coli K-120.3
50S ribosomal protein L14Escherichia coli K-120.3
50S ribosomal protein L16Escherichia coli K-120.3
50S ribosomal protein L23Escherichia coli K-120.3
30S ribosomal protein S15Escherichia coli K-120.3
50S ribosomal protein L17Escherichia coli K-120.3
50S ribosomal protein L21Escherichia coli K-120.3
50S ribosomal protein L30Escherichia coli K-120.3
50S ribosomal protein L6Escherichia coli K-120.3
30S ribosomal protein S14Escherichia coli K-120.3
30S ribosomal protein S17Escherichia coli K-120.3
30S ribosomal protein S1Escherichia coli K-120.3
50S ribosomal protein L18Escherichia coli K-120.3
50S ribosomal protein L2Escherichia coli K-120.3
50S ribosomal protein L3Escherichia coli K-120.3
50S ribosomal protein L24Escherichia coli K-120.3
50S ribosomal protein L4Escherichia coli K-120.3
50S ribosomal protein L22Escherichia coli K-120.3
50S ribosomal protein L5Escherichia coli K-120.3
30S ribosomal protein S21Escherichia coli K-120.3
50S ribosomal protein L25Escherichia coli K-120.3
50S ribosomal protein L36 2Escherichia coli K-120.3

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's1 (12.50)24.3611
2020's6 (75.00)2.80

Authors

AuthorsStudies
Duff, P1
Caro-Vega, JM; García-Quintanilla, M; McConnell, MJ; Moreno-Martínez, P; Pachón, J; Pulido, MR1
Allen, VG; Bharat, A; Eshaghi, A; Mulvey, MR; Patel, SN; Zittermann, S1
Aydoğan, CN; Bozdoğan, B; Gümral, R; Hoşbul, T; Kaya, S; Levent, B; Şahiner, F; Türkmen Albayrak, H1
Camacho-Ortiz, A; Flores-Treviño, S; Garza-González, E; Lara-Medrano, R; Martínez-Reséndez, MF; Mendoza-Olazarán, S1
Barker, KR; Britton, PN; Campigotto, A; Castelli, F; Chan, T; Earl, AM; Farrar, DS; Fumadó, VP; Hagmann, SHF; Hamer, DH; LaRocque, RC; Libman, M; Morris, SK; Posen, HJ; Ryan, ET; Wong, W; Worby, CJ1
Goy, K; Luna, B; Miller, S; She, R; Spellberg, B1
Bissong, MEA; Mkong, PB; Mobey, KN; Muma, V1

Reviews

1 review(s) available for carbapenems and zithromax

ArticleYear
Antibiotic selection in obstetrics: making cost-effective choices.
    Clinical obstetrics and gynecology, 2002, Volume: 45, Issue:1

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Carbapenems; Cephalosporins; Clindamycin; Cost-Benefit Analysis; Female; Fluoroquinolones; Humans; Linezolid; Metronidazole; Nitrofurantoin; Oxazolidinones; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination

2002

Other Studies

7 other study(ies) available for carbapenems and zithromax

ArticleYear
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amidohydrolases; Amikacin; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline; Vancomycin

2016
Importation of Extensively Drug-Resistant Salmonella enterica Serovar Typhi Cases in Ontario, Canada.
    Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5

    Topics: Anti-Bacterial Agents; Azithromycin; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Ontario; Pakistan; Salmonella enterica; Travel; Typhoid Fever; Whole Genome Sequencing

2020
[Investigation of Azithromycin Minimum Inhibitory Concentration Values and Carbapenem Resistance in Salmonella and Shigella Clinical Isolates].
    Mikrobiyoloji bulteni, 2021, Volume: 55, Issue:4

    Topics: Anti-Bacterial Agents; Azithromycin; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Salmonella; Shigella

2021
Azithromycin effect on multidrug resistant Acinetobacter baumannii biofilm production and composition.
    Gaceta medica de Mexico, 2021, Volume: 157, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Azithromycin; Biofilms; Carbapenems; Humans

2021
Travel-associated extensively drug-resistant typhoid fever: a case series to inform management in non-endemic regions.
    Journal of travel medicine, 2023, 02-18, Volume: 30, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Carbapenems; Humans; Pakistan; Salmonella typhi; Travel; Typhoid Fever

2023
Antimicrobial Susceptibility Testing Performed in RPMI 1640 Reveals Azithromycin Efficacy against Carbapenem-Resistant Acinetobacter baumannii and Predicts
    Antimicrobial agents and chemotherapy, 2023, 01-24, Volume: 67, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Azithromycin; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Moths

2023
Reduced susceptibility to carbapenems in
    The Pan African medical journal, 2023, Volume: 44

    Topics: Animals; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Cameroon; Carbapenems; Cattle; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Microbial Sensitivity Tests

2023